Preemptive celecoxib cuts post-op face-lift surgery pain

(HealthDay)—Preemptive treatment with oral celecoxib appears to be effective in decreasing acute postoperative pain in patients undergoing face-lift surgery, according to a study published online July 10 in JAMA Facial Plastic Surgery.

Behrad B. Aynehchi, M.D., from Lenox Hill Hospital in New York City, and colleagues reviewed the medical records of 100 patients: 50 consecutive patients who underwent a face-lift without receiving perioperative and 50 patients who underwent face-lift and received immediate preoperative and standing postoperative celecoxib.

The researchers found that the two groups of participants had similar demographic characteristics, including that 94 percent of both groups were women. In the non-celecoxib group, scores were higher compared to the celecoxib groups (P < 0.001). Compared to the celecoxib group, the non-celecoxib group had a higher number of postoperative opioid doses (P < 0.05) and had a higher incidence of postoperative nausea and vomiting.

"Given the well-documented adverse effects of opioids, celecoxib is a desirable alternative," the authors write.


Explore further

FDA approves generic version of celebrex

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2014 HealthDay. All rights reserved.

Citation: Preemptive celecoxib cuts post-op face-lift surgery pain (2014, July 23) retrieved 16 October 2019 from https://medicalxpress.com/news/2014-07-preemptive-celecoxib-post-op-face-lift-surgery.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more